CAPITAL FUND MANAGEMENT S.A.

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1323645 PARIS, I0

Position in IONS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$10,677,873

+$9,444,411 QoQ

Shares Held

142,201

+355.5% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. IONS ranks #7 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	122,934	$54,894,948
2	ALNY	Alnylam Pharmaceuticals, Inc.	140,109	$46,357,864
3	INCY	Incyte Corp	312,021	$29,367,416
4	MRNA	Moderna, Inc.	569,930	$28,952,444
5	EXEL	Exelixis, Inc.	479,693	$20,574,032
6	HALO	Halozyme Therapeutics, Inc.	174,378	$11,270,050
7	IONS	Ionis Pharmaceuticals Inc This page	142,201	$10,677,873
8	BMRN	Biomarin Pharmaceutical Inc	181,065	$10,228,361

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,677,873	142,201	+355.5%	Shares	Sole	2026-05-14
2025-06-30	$1,233,462	31,219	-46.2%	Shares	Sole	2025-08-13
2025-03-31	$1,750,282	58,014	+89.0%	Shares	Sole	2025-05-14
2024-09-30	$1,229,481	30,691	+171.3%	Shares	Sole	2024-11-13
2023-03-31	$404,362	11,314	-50.9%	Shares	Sole	2023-05-15
2022-09-30	$1,018,307	23,023	-41.1%	Shares	Sole	2022-11-14
2022-06-30	$1,447,852	39,110	-12.5%	Shares	Sole	2022-08-12
2022-03-31	$1,656,391	44,719	+59.1%	Shares	Sole	2022-05-12
2021-12-31	$855,326	28,108	+18.2%	Shares	Sole	2022-02-10
2020-09-30	$1,128,503	23,783	-28.2%	Shares	Sole	2020-11-13
2020-03-31	$1,565,488	33,111	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.